Srdjan Stankovic

President

Other

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Acadia Pharmaceuticals Inc (ACAD)	—	$755,103	—	$4,657,377	$1,900,838	$459,041	$25,268	$7,797,628
2021	Acadia Pharmaceuticals Inc (ACAD)	—	$739,377	—	$1,957,468	$1,979,073	$149,008	$44,711	$4,869,637
2020	Acadia Pharmaceuticals Inc (ACAD)	—	$715,869	—	$1,864,547	$1,870,608	$379,813	$25,577	$4,856,415
2019	Acadia Pharmaceuticals Inc (ACAD)	—	$693,563	—	$1,932,331	$1,924,767	$517,401	$20,208	$5,088,270
2018	Acadia Pharmaceuticals Inc (ACAD)	—	$524,785	—	$705,700	$4,094,313	$334,289	$19,294	$5,678,381

Earnings-call appearances

Acadia Pharmaceuticals Inc Q3 FY2022 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2022-11-02
Acadia Pharmaceuticals Inc Q2 FY2022 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2022-08-08
Acadia Pharmaceuticals Inc Q4 FY2021 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2022-02-28
Acadia Pharmaceuticals Inc Q2 FY2021 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2021-08-04
Acadia Pharmaceuticals Inc Q2 FY2020 Earnings Call
Acadia Pharmaceuticals Inc (ACAD)

2020-08-05